Correlation Between Oasmia Pharmaceutical and HUTCHMED DRC
Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oasmia Pharmaceutical AB and HUTCHMED DRC, you can compare the effects of market volatilities on Oasmia Pharmaceutical and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and HUTCHMED DRC.
Diversification Opportunities for Oasmia Pharmaceutical and HUTCHMED DRC
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oasmia and HUTCHMED is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and HUTCHMED DRC go up and down completely randomly.
Pair Corralation between Oasmia Pharmaceutical and HUTCHMED DRC
If you would invest 6.00 in Oasmia Pharmaceutical AB on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Oasmia Pharmaceutical AB or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.56% |
Values | Daily Returns |
Oasmia Pharmaceutical AB vs. HUTCHMED DRC
Performance |
Timeline |
Oasmia Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
HUTCHMED DRC |
Oasmia Pharmaceutical and HUTCHMED DRC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oasmia Pharmaceutical and HUTCHMED DRC
The main advantage of trading using opposite Oasmia Pharmaceutical and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.Oasmia Pharmaceutical vs. Thor Industries | Oasmia Pharmaceutical vs. Modine Manufacturing | Oasmia Pharmaceutical vs. FDG Electric Vehicles | Oasmia Pharmaceutical vs. Summit Materials |
HUTCHMED DRC vs. Emergent Biosolutions | HUTCHMED DRC vs. Bausch Health Companies | HUTCHMED DRC vs. Neurocrine Biosciences | HUTCHMED DRC vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |